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Background: There is increasing recognition of gaps between best scientific evidence and clinical practice. This
systematic review aimed to assess the volume and scope of peer-reviewed cancer research output in the years
2000, 2005, and 2010.
Methods: Eligible papers were published in English and reported on evidence-practice gaps in cancer care. The
electronic database Medline was searched for three time periods using MeSH headings and keywords. Abstracts
were assessed against eligibility criteria by one reviewer and checked by a second. Papers meeting eligibility criteria
were coded as data-based or non-data-based, and by cancer type of focus. All data-based papers were then further
classified as descriptive studies documenting the extent of, or barriers to addressing, the evidence-practice gap; or
intervention studies examining the effectiveness of strategies to reduce the evidence-practice gap.
Results: A total of 176 eligible papers were identified. The number of publications significantly increased over time,
from 25 in 2000 to 100 in 2010 (p < 0.001). Of the 176 identified papers, 160 were data-based. The majority of these
(n = 150) reported descriptive studies. Only 10 studies examined the effectiveness of interventions designed to
reduce discrepancies between evidence and clinical practice. Of these, only one was a randomized controlled trial.
Of all data-based studies, almost one-third (n = 48) examined breast cancer care.
Conclusions: While the number of publications investigating evidence-practice gaps in cancer care increased over
a ten-year period, most studies continued to describe gaps between best evidence and clinical practice, rather than
rigorously testing interventions to reduce the gap.
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NeoplasmsBackground
The importance of reducing evidence-practice gaps in
healthcare
Evidence-based practice is the ‘conscientious, explicit and
judicious use of current best evidence in making decisions
about the care of individual patients’ [1]. There is increas-
ing recognition of gaps between best scientific evidence
and clinical practice in many fields of healthcare [2-5]. It
has been estimated that up to 40% of patients fail to re-
ceive treatments shown to be effective [4], while 20% to
25% receive treatments that are not needed, or potentially
harmful [5]. Reducing the gap between best evidence and* Correspondence: Jamie.Bryant@newcastle.edu.au
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unless otherwise stated.clinical practice is associated with reductions in patient
morbidity and mortality [6-8], and reduced healthcare
costs [9]. In the past ten years, increasing attention has
been directed to addressing barriers to the translation of
research into clinical practice to improve patient out-
comes [10-12].Concern about evidence-based practice in cancer care
The past decade has been marked by increases in both
cancer incidence and survival [13,14]. However, concern
about disparities between best-evidence practice and can-
cer care has persisted for some time. In the 1999 report
‘Ensuring Quality Cancer Care’ [15], the US National Can-
cer Policy Board stated that ‘reasons for failure to deliver
high-quality care have not been studied adequately’ (pg 4).
The report made a number of recommendations, includingLtd. This is an Open Access article distributed under the terms of the Creative
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mented to ensure optimal care is provided to patients, and
that the quality of care provided be measured and moni-
tored [15]. Awareness of the need to address evidence-
practice gaps in cancer care was further heightened by the
landmark 2001 Institute of Medicine report ‘Crossing the
Quality Chasm’ , which identified that high rates of misuse,
underuse, and overuse of health services have created a
‘chasm’ between best evidence and medical practice [16].
Volume of research output as a measure of research
effort
Given increased acknowledgement of the need to ad-
dress evidence-practice gaps in cancer care, it might be
expected that research efforts to ensure effective transla-
tion of knowledge into clinical practice would also have
increased over this time period. Although not without
limitations [17], examining the volume of peer-reviewed
research output using bibliometric methods is a proxy
indicator of scientific productivity [18,19]. Volume of re-
search output provides information about the research
capacity of a field, including the areas where research
funding has been allocated, and where clinician and re-
searcher effort have been directed.
Research design as a measure of progression of research
effort
While volume of research output provides an indication
of the amount of work being conducted in a particular
field, it fails to provide information about the type or
quality of work. The effective translation of evidence
into practice is complex and depends on a number of
factors, one of which is the type of research evidence
generated [20]. To advance evidence-based practice, a
logical progression of research is required. First, there is
need to examine whether there is a discrepancy between
current practice and best-evidence practice, and if so,
the magnitude of the discrepancy. If a gap is found that
is likely to have clinically or economically important im-
plications, research is then needed to develop evidence
about how best to effectively reduce this gap. Methodo-
logically rigorous intervention studies are critical to pro-
duce evidence about the most effective strategies for
delivering best practice healthcare. Interventions might
aim to educate clinicians [21], change the practice envir-
onment [22], or change contingencies [23].
In 2010, Evensen et al. [24] examined the number of
published studies related to the evidence-practice gap
across nine specific guidelines related to family medi-
cine, three of which related to cancer. While a large
number of studies were identified, only 15% of the stud-
ies were intervention studies and few met quality criteria
for methodological rigor established by the Cochrane Ef-
fective Practice and Organization of Care (EPOC) Group[25]. Providing optimal care to the increasing population
of cancer patients and survivors has been described as a
public health challenge [26]. Translational step three
(T3) of the National Institutes of Health Roadmap [27]
argues that there is a need for research to examine
translation of evidence generated into the clinical care
provided to patients. However to date, there has been no
examination of the research attention given to imple-
mentation of evidence into clinical care at the T3 level
in the wider cancer literature.Aims
To examine in the cancer literature in the years 2000,
2005 and 2010:
1. The number of publications examining evidence-
practice gaps;
2. The number of data-based versus non-data-based
publications examining evidence-practice gaps, in-
cluding the number describing evidence practice
gaps compared to the number evaluating interven-
tions to reduce evidence practice gaps;
3. The number of data-based publications examining
evidence-practice gaps by cancer type and research
design.Methods
Inclusion and exclusion criteria
Eligible papers were those published in English in 2000,
2005, and 2010 that reported on evidence-practice gaps
in cancer care. The year 2000 was selected as the start-
ing point for this review given that the influential report
by the National Cancer Board was published in 1999
[15]. Studies examining the effectiveness of treatments
on cancer recurrence, disease-free survival, or overall sur-
vival were excluded, as were studies examining evidence-
practice gaps for cancer screening, editorials, letters to the
editor, dissertations, and protocol papers.Literature search
The electronic database Medline was searched using the
OVID platform. The search strategy included three cat-
egories of search terms: guideline adherence/evidence
based practice, cancer, and treatment types (full search
strategy available in Additional file 1). Medline was se-
lected as the database of choice given its focus on bio-
medicine and health publications in scholarly journals.
Searches were restricted to English language publications
and human studies. A Google Scholar search using com-
binations of the above keywords was also conducted to
ensure relevant papers were not missed. A copy of the
review protocol is available in Additional file 2.
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Retrieved abstracts were initially assessed against the eli-
gibility criteria by one reviewer (JB) and rejected if the
reviewer determined from the title and abstract that the
study did not meet inclusion criteria. Full text copies of
the remaining publications were retrieved and further
assessed against eligibility criteria to confirm or refute
inclusion. Papers meeting the eligibility criteria were then
categorized as follows:
1. Data-based or non-data-based: Data-based
publications were those reporting new data or
new analysis of existing data. Non-data-based
publications included review, commentary, discussion,
or summary papers.
2. Cancer type: All data-based papers were classified
according to the cancer type of the study sample
according to the International Classification of
Diseases for Oncology [28] and body system-specific
cancer classification.
3. Research design: All data-based papers were further
classified into one of the following categories:
Descriptive studies using cross-sectional study designs
to document or describe the evidence-practice gap
or barriers to addressing the evidence-practice gap;
Intervention studies using experimental designs to
test strategies to reduce the evidence practice gap.
Studies using an experimental design were also
assessed as to whether the design was one of the four
types allowed by the EPOC criteria- randomized
controlled trials, clinical controlled trials, controlled
before and after studies, or interrupted time series
studies.
A random sample of 10% of papers identified as eligible
was checked for relevance and double-coded by a second
reviewer (MC).Analysis
Chi-Square tests for equal proportions were conducted
to determine whether the total volume of research output
changed over time, and whether the number of descriptive
studies changed over time.Results
Search results
A total of 4,507 citations were retrieved using the key
words. After assessment against the eligibility criteria and
double coding by a second reviewer (with 100% agreement
achieved), 176 relevant studies meeting the eligibility
criteria were included in the review (Figure 1). A list of
included citations is provided in Additional file 3.Volume of research output over time
Of the 176 relevant publications addressing evidence-
practice gaps in cancer, 25 were published in 2000, 51 in
2005, and 100 in 2010 (see Figure 2). There was a sig-
nificant increase in the total number of publications over
time (p < 0.001).
Number of data-based versus non-data-based
publications
The number of data-based and non-data-based publications
addressing evidence-practice gaps in cancer are reported in
Figure 2. A total of 160 data-based and 16 non-data-based
publications were identified.
Number of data-based publications by cancer type
The distribution of data-based studies by cancer type is
reported in Figure 3. The cancer type with the highest
number of publications was breast cancer (48 publica-
tions), followed by studies with heterogeneous samples
of cancer types (30 publications). Four papers examining
provider behavior could not be coded by cancer type.
Number of data-based publications by research design
Of the 160 data-based publications identified, the large
majority (n = 150) used cross-sectional designs to de-
scribe evidence-practice gaps (Figure 4). Only ten studies
reported on the effect of an intervention designed to re-
duce an evidence-practice gap. Of these, one used a ran-
domized controlled design, one used a controlled before
and after design, and the remainder used pre/post de-
signs without a control condition. There was a signifi-
cant increase in the number of descriptive studies over
time (p < 0.001), however the number of intervention
studies did not increase over time.
Discussion
Reducing the gap between best evidence and clinical
practice in cancer care will improve patient morbidity
and mortality [6-8] and reduce healthcare costs [9]. This
review identified a small volume of research in cancer
care addressing this important issue. Of the 176 publica-
tions identified, the majority (91%) provided new data.
Only 9% of publications were reviews, commentaries, or
summaries of the existing evidence base. This is an en-
couraging finding and suggests that a substantial propor-
tion of research effort is directed toward empirical work.
However, further examination revealed that 94% of data-
based publications were descriptive studies, with only
ten intervention studies identified. The number of inter-
vention studies did not increase over time. Studies most
commonly focused on breast cancer care.
While descriptive research provides important informa-
tion about current practice, it does not maximize research
benefits by comparing the effectiveness of approaches to
Met inclusion criteria
N = 176
Excluded: N = 63 
N = 17 letter, editorial or comment
N = 14  treatment efficacy or effectiveness
N = 9 quality of care
N = 11 validation, need for, or development of 
guidelines
N = 7 impact of treatment on survival
N = 2 cancer screening 
N = 1 modeling of potential evidence practice gap











Figure 1 Flow chart of search strategy and study selection.
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and in particular the small number that used rigorous
evaluation designs, may be explained by the difficulty of
carrying out well-controlled intervention trials in this
field. Changes to clinical practice may require changes to
processes of care, clinician knowledge, and organizational
culture, so the unit of analysis for such studies is often the



































Figure 2 Number of publications addressing the evidence-practice
gap in cancer care in 2000, 2005 and 2010.interventions are often incompatible with randomized
controlled designs where the unit of randomization is the
individual [29]. An alternative to the traditional random-
ized controlled trial suitable for evaluating interventions
involving organizational change is the cluster randomized
controlled trial. However, this design poses complex logis-
tical challenges, such as the need to obtain agreement for
implementation from all clinicians within the cluster, diffi-
culties obtaining a large enough sample of hospitals or
clinics, and the substantial costs associated with evaluating
the intervention across many sites [30]. Intervention stu-
dies also require multi-disciplinary collaboration and a
specific repertoire of research skills, while descriptive re-
search requires relatively less time and fewer resources. In
a professional environment where both volume and im-
pact of research output is valued, researchers may be more
motivated to undertake descriptive work rather than com-
plex and time intensive intervention studies, or focus their
effort on randomized controlled trials of individual-level
interventions. The design challenges may be overcome by
the use of alternative research designs such as interrupted
time series or multiple baseline designs, and by commit-





























Figure 3 Distribution of data-based studies by cancer type (N = 160).
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strategies to close the evidence-practice gap may also be
important to increasing productivity in this area.
The small number of intervention trials may also be
the result of a perception in clinical oncology that opti-
mal cancer care is already being delivered to patients
and, therefore, research to ensure translation of clinical
research into practice is not needed. It is simplistic to
presume, however, that new evidence is routinely inte-
grated into clinical practice guidelines, policy, and then
clinical care [31,32]. Changing established patterns of
care is difficult, and often necessitates the involvement
of cancer patients and their advocacy groups, individual
practitioners, senior administrators of healthcare organi-
zations, and policy makers [32]. Passive dissemination of
evidence via clinical practice guidelines and publications
produce only small changes in clinical practice, and
there is insufficient evidence to show that such strategies
have any effect on patient outcomes [33]. Further, uptake
of new evidence is inconsistent even when active imple-


































Figure 4 Number of descriptive and intervention studies
addressing the evidence-practice gap in cancer care in 2000,
2005 and 2010.one descriptive study examined the impact of the American
Society of Clinical Oncology (ASCO) guidelines regarding
use of hematopoietic colony-stimulating factors (CSF) on
cancer care. Six months after active dissemination and im-
plementation of the guidelines, it found that only 61% of
CSF prescriptions complied with ASCO guidelines [35]. In
addition, the finding that 94% of data-driven papers iden-
tified in this review described evidence-practice gaps in
cancer care highlights the importance of increasing imple-
mentation research effort in the field.
The finding that a large proportion of research effort
has been directed toward breast cancer care is in accord-
ance with previous findings that breast cancer research
dominates the quality of life research field [36]. Prostate
cancer is similar to breast cancer in terms of incidence
[37], and other high-incidence cancers such as lung can-
cer and bowel cancer have higher mortality rates than
breast cancer [37]. Therefore, the focus on breast cancer
is not likely to reflect burden, but rather the high profile
of this disease and the availability of specific funding for
breast cancer research. This suggests a need for more ef-
fort toward examining and addressing evidence-practice
gaps in care for other cancers with poor outcomes.
Limitations
These results should be considered in light of several limi-
tations. First, grey literature such as reports, policy docu-
ments, and dissertations were not included, nor were
protocol papers. While this information may be relevant,
grey literature is not peer-reviewed and therefore may not
meet the high standards of quality associated with peer-
reviewed publication. Inclusion of grey literature may also
have biased the review given that papers related to work
known by the authors and their network would have been
more likely to have been identified than other works. Se-
cond, only one author screened the retrieved citations/
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double coded by a second reviewer with perfect agree-
ment, this is a limitation of the search execution. Third,
there are limitations to using volume of research output
as a measure of research effort [36,38]. Due to publication
bias, studies with unfavorable results may not be pub-
lished, leading to under-representation of the true amount
of work carried out in the field [39,40]. Finally, only stu-
dies that self-identified as addressing the evidence-practice
gap in cancer care were included. While this may have
resulted in some relevant studies not being included, it
was not feasible to retrospectively define whether studies
were addressing evidence-practice gaps. The use of a
large number of search terms that covered evidence-
based practice, guideline development, and the evidence-
practice gap is likely to have limited the number of rele-
vant studies missed. However, the large number of ways
papers relating to evidence-practice gaps or implementa-
tion science are indexed is a limitation, compromising
the ability of the field to advance in an optimal fashion.
Conclusions
Reducing discrepancies between best evidence and clinical
practice is an area of ongoing need across all fields of
healthcare. A prerequisite for the effective transfer of evi-
dence into practice is methodologically rigorous research
that identifies where evidence-practice gaps exist, and de-
velops and tests interventions to close the gap. The small
number of intervention studies addressing evidence-
practice gaps in cancer care highlights a clear need to
shift research efforts from descriptive studies to robust
experimental studies if patients are to receive optimal
care. The relatively high number of studies on the trans-
lation of evidence into practice in breast cancer care
suggests that greater research effort should be directed
towards other cancers with high incidence and disease
burden such as lung cancer.
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